A Pilot Randomised Controlled Trial of Cognitive Behaviour Therapy for Early Bipolar Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mania
- Sponsor
- NHS Greater Glasgow and Clyde
- Enrollment
- 20
- Locations
- 2
- Primary Endpoint
- Montgomery Asberg Depression Rating Scale (MADRS) (Montogomery and Asberg, 1979)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
There is a need to develop a better understanding of the early phase of bipolar disorder, and to develop and evaluate effective psychosocial interventions that assist people in this phase. The purpose of this study is to determine whether or not it is feasible to conduct a larger study of the effectiveness of cognitive interpersonal therapy (a psychological therapy) with individuals who have experienced their first or second treated episode of mania or hypomania (symptoms common in early development of bipolar disorders).
Detailed Description
The 'PICO' framework (Oxman, Sackett, and Guyatt, 1993; Richardson, Wilson, Nishikawa, and Hayward; 1995) was used to specify the parameters of the study aims and objectives: 1. Population: could appropriate individuals be identified and recruited to a trial of CIT for early bipolar disorder? 2. Intervention: would CIT be an acceptable intervention for individuals following a first or second treated episode of mania and or hypomania? Could we identify any modifications required to the CIT protocol used with this group? 3. Control group: could an appropriate group of participants be recruited to facilitate a comparison with the CIT intervention? Could we explicitly establish the usual care package and its local implementation? 4. Outcomes: which outcomes are appropriate for measuring relevant dimensions of a treatment effect?
Investigators
Jamie Kirk
Clinical Psychologist / Chief Investigator
NHS Greater Glasgow and Clyde
Eligibility Criteria
Inclusion Criteria
- •Eligible individuals will have experienced their first or second treated episode of mania and / or hypomania in the previous 12-months prior to study entry.
Exclusion Criteria
- •Participants will be excluded if there is a (1) diagnosis of learning disability; (2) inability to participate in psychotherapy/research due to acute medical condition or acute mania
Outcomes
Primary Outcomes
Montgomery Asberg Depression Rating Scale (MADRS) (Montogomery and Asberg, 1979)
Time Frame: Baseline to End of Study.
The Montgomery Asberg Depression Rating Scale (MADRS) (Montgomery and Asberg, 1979) is a semi-structured interview designed to assess the presence and severity of 10 core symptoms of depression. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. The questionnaire includes questions on the following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts. Usual cutoff points are: 0 to 6 - normal /symptom absent 7 to 19 - mild depression 20 to 34 - moderate depression \>34 - severe depression
Bech-Rafaelsen Mania Rating Scale (BRMS) [Bech et al, 1979]
Time Frame: Baseline to End of Study
The Bech-Rafaelsen Mania Rating Scale (BRMS) \[Bech et al, 1979\] provides a structured format for a clinician to assess the presence and severity of 11 core symptoms of hypomania or mania.Higher BRMS score indicates more severe symptoms of mania, and each item yields a score of 0 to 4. The overall score ranges from 0 to 44. Usual cutoff points are: 0 to 15 - normal /symptom absent 15 to 20 - mild 21 to 28 - moderate \>34 - severe
Secondary Outcomes
- The Internal State Scale (ISS) (Bauer et al, 1991)(monthly until October 2011)
- Global Assessment of Functioning (GAF)(monthly until October 2011)